Sep 30, 2022

Entrada Therapeutics Q3 2022 Earnings Report

EPS
-$0.8
Previous year: -$9.78
-91.8%
Cash and Equivalents
$53.3M
Previous year: $122M
-56.4%
Free Cash Flow
-$28.3M
Previous year: -$14.9M
+90.1%
Total Assets
$274M
Previous year: $132M
+107.3%

Entrada Therapeutics

Entrada Therapeutics